Images of the East African Training in Ethiopia

Following are some of the transformative efforts underway by NewYork-Presbyterian/Columbia University Medical Center physicians to bring expertise in pulmonary medicine to countries in dire need of such specialized care.

Searching for approaches to address ongoing challenges, a number of studies and clinical trials are evaluating new approaches for neoadjuvant therapies and early phase clinical trials to assess novel therapeutic agents based on tumor genomics.

In the past 50 years, use of neoadjuvant chemotherapy for breast cancer has evolved. Today, clinicians at NewYork-Presbyterian are using neoadjuvant therapy to tackle residual tumor.

Surgeons at NewYork-Presbyterian/Columbia are turning up the heat (or cold as the case may be) on early-stage breast cancer tumors with the use of ablation therapies.

Charles G. Drake was presented with a unique opportunity to build a genitourinary cancer group with the focus on trying to cure these cancers with the immune system.

The promise of immunotherapy is altering how many cancers are perceived and treated, but it has so far eluded the treatment for some of the more aggressive malignancies, including ovarian cancer.

To address this often under-recognized and misdiagnosed condition in children and adolescents, NewYork-Presbyterian established the Center for Youth Mental Health in 2013 in association with Weill Cornell Medicine and Columbia University Medical Center.